PTGX
Protagonist Therapeutics Inc Earnings
$98.67
Earnings Summary
Revenue | $7.44Mn |
Net Profits | $-44.38Mn |
Net Profit Margins | -596.8% |
Protagonist Therapeutics Inc’s revenue fell -95.64% since last year same period to $7.44Mn in the Q4 2025. On a quarterly growth basis, Protagonist Therapeutics Inc has generated 57.83% jump in its revenue since last 3-months.
Protagonist Therapeutics Inc’s net profit fell -133.71% since last year same period to $-44.38Mn in the Q4 2025. On a quarterly growth basis, Protagonist Therapeutics Inc has generated -12.82% fall in its net profits since last 3-months.
Protagonist Therapeutics Inc’s net profit margin fell -873.4% since last year same period to -596.8% in the Q4 2025. On a quarterly growth basis, Protagonist Therapeutics Inc has generated 28.52% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.5 |
EPS Estimate Current Year | -0.5 |
Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.5 - a -48.08% fall from last quarter’s estimates.
Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.5.
Key Ratios
Earning Per Share (EPS) | 0 |
Protagonist Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Protagonist Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-06 | -0.5 | 0 | 100% |
